Cargando…
Gut Dysbiosis: A New Avenue for Stroke Prevention and Therapeutics
A stroke is a serious life-threatening condition and a leading cause of death and disability that happens when the blood vessels to part of the brain are blocked or burst. While major advances in the understanding of the ischemic cascade in stroke was made over several decades, limited therapeutic o...
Autores principales: | Park, Shin Young, Lee, Sang Pyung, Kim, Dongin, Kim, Woo Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525294/ https://www.ncbi.nlm.nih.gov/pubmed/37760793 http://dx.doi.org/10.3390/biomedicines11092352 |
Ejemplares similares
-
Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021) -
Efficacy and Gut Dysbiosis of Gentamicin-Intercalated Smectite as a New Therapeutic Agent against Helicobacter pylori in a Mouse Model
por: Jeong, Su Jin, et al.
Publicado: (2020) -
NOX Inhibitors - A Promising Avenue for Ischemic Stroke
por: Kim, Jong Youl, et al.
Publicado: (2017) -
New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
por: Lorente-Picón, Marina, et al.
Publicado: (2021) -
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
por: Kirby, Trevor O., et al.
Publicado: (2018)